The Deal Register
Database › Equity financing › ZYUS Life Sciences Announces Cancellation of LIFE Offering and Launch…

Equity financing

ZYUS Life Sciences Announces Cancellation of LIFE Offering and Launch of Private Placement

Lane
Equity financing
Announced
24 Feb 2026
Province
Saskatchewan
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a clinical stage life sciences company focused on the development and commercialization of novel non‑opioid drug candidates for pain management, today announces the Company has elected to cancel its previously announced brokered private placement offering (the " LIFE Offering "), which was originally announced on January 12, 2026 and amended and restated on February 9, 2026.
Terms stated
interest rate, price per security
Source

The terms are in the subscriber edition

This transaction carries 2 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe